首页> 美国卫生研究院文献>Current Oncology >Chinese medicine and biomodulation in cancer patients—Part one
【2h】

Chinese medicine and biomodulation in cancer patients—Part one

机译:癌症患者的中医药与生物调节-第一部分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traditional Chinese Medicine (tcm) may be integrated with conventional Western medicine to enhance the care of patients with cancer. Although tcm is normally implemented as a whole system, recent reductionist research suggests mechanisms for the effects of acupuncture, herbs, and nutrition within the scientific model of biomedicine. The health model of Chinese medicine accommodates physical and pharmacologic interventions within the framework of a body–mind network. A Cartesian split does not occur within this model, but to allow for scientific exploration within the restrictions of positivism, reductionism, and controls for confounding factors, the components must necessarily be separated. Still, whole-systems research is important to evaluate effectiveness when applying the full model in clinical practice. Scientific analysis provides a mechanistic understanding of the processes that will improve the design of clinical studies and enhance safety. Enough preliminary evidence is available to encourage quality clinical trials to evaluate the efficacy of integrating tcm into Western cancer care.
机译:中医(tcm)可以与常规西药结合使用,以增强对癌症患者的护理。尽管tcm通常作为一个整体系统实施,但最近的还原主义者研究表明,在生物医学的科学模型中,针灸,草药和营养作用的机制。中医健康模型在身心网络的框架内提供物理和药物干预。在此模型中不会发生笛卡尔分裂,但是为了允许在实证主义,还原主义和混杂因素的控制范围内进行科学探索,必须将各个组成部分分开。尽管如此,将完整模型应用于临床实践时,整个系统的研究对于评估有效性仍然很重要。科学分析提供了对过程的机械理解,将改善临床研究的设计并提高安全性。已有足够的初步证据来鼓励进行高质量的临床试验,以评估将tcm纳入西方癌症治疗的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号